Archil Jaliashvili: What if Normal Hb and SpO₂ Still Do not Mean Adequate Tissue Oxygenation?
Archil Jaliashvili, Co-Chief Executive Officer at GeoBio Pharm, Biotech Executive, Strategic Partner of BHOC and Precision Oxygen Therapeutics, shared a post on LinkedIn:
“What if normal Hb and SpO₂ still do not mean adequate tissue oxygenation?
This new review raises exactly this question.
In severe inflammation and critical illness, the problem is not simply how much oxygen is present in the blood.
- Endothelial dysfunction.
- Microcirculatory impairment.
- Edema.
- Microthrombosis.
- Altered NO biology.
- Longer oxygen diffusion distance.
All of these can determine whether oxygen actually reaches the tissue.
This is why I believe we need to move beyond thinking only in terms of hemoglobin, saturation and macrocirculation.
We need a broader concept: Precision Oxygenation Therapeutics.
The therapeutic objective should not simply be to improve numbers in the bloodstream.
It should be to maintain effective oxygen availability where it is actually needed at the tissue level.
This also creates an important research question for BHOC and next-generation HBOCs.
Not as a replacement for RBCs.
But as a complementary oxygen-delivery platform that may help support tissue oxygenation when conventional RBC-dependent transport, endothelial
regulation and microcirculation become physiologically limited.
The future question may therefore be less:
‘How much hemoglobin do we have?’
and more:
‘How much oxygen is actually reaching the tissue and can we control this more precisely?'”
Title: The Potential for Severe, Acute Inflammation to Impact Tissue Oxygenation—A Narrative Review
Authors: Alan Nimmo, Alexander Younsi
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 22, 2026, 16:48Ahmed Alotaibi: Rare Rh Phenotype and Severe Fetal Anaemia
-
Oct 22, 2026, 16:36Alissa Odum: Every Blood Type Matters Every Donation Saves Lives
-
Oct 22, 2026, 16:33Mehul Malhotra: Targeted Therapies and Clinical Advances Transform the wAIHA Treatment Landscape
-
Oct 22, 2026, 16:13William Wallace: The Hidden Neurological Impact of Vitamin B12 Deficiency
-
Oct 22, 2026, 16:06Akram Farhadi: Anemia and Low Hemoglobin Associated With Higher Risk of Osteosarcopenia in Older Adults
-
Oct 22, 2026, 15:49Javed Iqbal: NUMC Pulmonary and Critical Care Team Showcases Research at CHEST 2026
-
Oct 22, 2026, 15:37Alina Mitina: Key Concerns Surrounding DVT and Pulmonary Embolism
-
Oct 22, 2026, 14:45Seyed Mehrab Safdari: Prenatal Diagnosis in Hemophilia – Two Decades of Progress and Remaining Challenges
-
Oct 22, 2026, 14:39Mahmoud Abdelnabi: Evaluating the Evidence on Elevated Lp(a) and VTE Before Clinical Translation